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In vitro cytotoxicity assays have a crucial role in determining the functionality and potency levels of various 
immune cells, including both NK and T-cells. A flow cytometry based cytoxicity assay is commonly used to 
measure the levels of cell-mediated killing of a target cancer cell. The assay involves staining the cancer cells 
along with a co-culture incubation step. The cytotoxicity value is typically reported as a percentage killing 
efficiency of the target cancer cell at a fixed effector-to-target ratio. In vitro cytotoxicity assays have commonly 
been used to provide valuable potency data and have many diverse applications for multiple cell types. 
 
We propose an alternative assay methodology which can improve accuracy over traditional cytotoxicity analysis 
methods. This new reporting method/approach can overcome signal saturation issues and allows for more 
consistent and meaningful outputs over a broader dynamic assay range. It also eliminates any potential 
extrapolation needed during analysis. This new method provides a means for a more robust cytotoxicity assay, 
resulting in a more valuable measuring tool. 
 
